CRC Becomes Accredited Medidata Rave® EDC Partner
With accreditation complete, CRC's data management team is fully equipped to design, build, and manage clinical trial databases within the Medidata Rave EDC platform, one of the most trusted technologies in the industry. Sponsors benefit from faster access to clean, validated data in a secure environment and real-time visibility that supports confident and timely decisions.
"Becoming an accredited Rave EDC partner reinforces what CRC is all about. We deliver precision and customized solutions at every step," said
CRC's accreditation reflects a broader commitment to integrating smart technology with high-touch execution. As CRC continues to deliver personalized support and high-quality data across complex CNS trials, the team remains focused on offering a better CRO experience through proactive solutions, streamlined operations, and trusted collaboration. Additional platform partnerships are being explored to further enhance value for sponsors.
About Cognitive Research Corporation
Cognitive Research Corporation (CRC) is a leading full-service clinical research organization, specializing exclusively in CNS disorders, including neurology, psychiatry, and analgesia. Combining innovative technology, deep scientific expertise, and personalized concierge support, CRC partners with sponsors, specialized sites, and CNS experts to deliver high-quality, efficient clinical trials across Phase I-III. Guided by a commitment to consistency, urgency, and accuracy, we help bring new therapies through rigorous testing to FDA approval, ultimately improving patient outcomes. Learn more at www.cogres.com.
Media Contact:
Director of Marketing, CRC
[email protected] | +1 (910) 742-5528
View original content to download multimedia:https://www.prnewswire.com/news-releases/crc-becomes-accredited-medidata-rave-edc-partner-302526935.html
SOURCE Cognitive Research Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
- BTC Price Holds Near $77K as Apeing Crypto Presale Stage 3 Goes Live at $0.0004, Raising Over $85K
- Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share